6 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Metamodix Competitors or Alternatives

Metamodix's top competitors include CymaBay, Blade Therapeutics and Akero.

Unlock 27 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Metamodix's company profile

Kedar Belhe

President & CEO

76/100
25 - 100
$5.7M
$5M - 25M
  • $5.7M
    $5M - 25M
  • 25 - 100
    $5.7M
  • $5M - 25M
  • 76/100
  • 25 - 100
  • $5.7M
  • $5M - 25M
View ProfileView
1
Metamodix's Competitor - CymaBay logo

Sujal Shah

President & CEO

90/100
60
$404.3M
$31.1M
  • $404.3M
    $31.1M
  • 60
    $404.3M
  • $31.1M
  • 90/100
  • 60
  • $404.3M
  • $31.1M
View ProfileView
2
Metamodix's Competitor - Blade Therapeutics logo

Wendye Robbins

President & CEO

97/100
25 - 100
$95M
$5M - 25M
  • $95M
    $5M - 25M
  • 25 - 100
    $95M
  • $5M - 25M
  • 97/100
  • 25 - 100
  • $95M
  • $5M - 25M
View ProfileView
3
Metamodix's Competitor - Akero logo

Andrew Cheng

President & CEO

86/100
30
$1.4B
  • $1.4B
  • 30
    $1.4B
  • 86/100
  • 30
  • $1.4B
View ProfileView
4
Metamodix's Competitor - vTv Therapeutics logo

Paul Sekhri

President & CEO

84/100
9
$311.2M
$1M
  • $311.2M
    $1M
  • 9
    $311.2M
  • $1M
  • 84/100
  • 9
  • $311.2M
  • $1M
View ProfileView
5
Metamodix's Competitor - Elcelyx Therapeutics logo

Alain D. Baron

President & CEO

79/100
1 - 25
$93.3M
$100K - 5M
  • $93.3M
    $100K - 5M
  • 1 - 25
    $93.3M
  • $100K - 5M
  • 79/100
  • 1 - 25
  • $93.3M
  • $100K - 5M
View ProfileView
Metamodix's top 30 competitors are CymaBay, Blade Therapeutics, Akero, Petra Pharma, vTv Therapeutics, Elcelyx Therapeutics, NGM Bio, Lixte Biotechnology, Intercept, Galectin, GENFIT, Aligos, Alnylam, Encycle Therapeutics, Zydus , AstraZeneca, Eidos, Indalo Therapeutics, Altimmune, Dicerna, Intarcia, Lilly, Progenra, XBiotech, Valeritas, ARMO BioSciences, Lexicon, Genentech, Amryt Pharma and Arcutis. Together they have raised over 24.3B between their estimated 179.3K employees. Metamodix's revenue is the ranked 16th among it's top 10 competitors. The top 10 competitors average 5.5B. Metamodix has 90 employees and is ranked 16th among it's top 10 competitors. The top 10 competitors average 5,787.

Metamodix VS CymaBay

CymaBay has been one of Metamodix's top competitors. CymaBay's headquarters is in Newark, California, and was founded in 1988. Like Metamodix, CymaBay also competes in the Biotechnology field. CymaBay generates 207% of Metamodix's revenue.

Metamodix VS Blade Therapeutics

Blade Therapeutics is one of Metamodix's top rivals. Blade Therapeutics is a Private company that was founded in South San Francisco, California in 2015. Like Metamodix, Blade Therapeutics also works within the Biotechnology industry. Blade Therapeutics has 65 fewer employees vs. Metamodix.

Metamodix VS Akero

Akero is perceived as one of Metamodix's biggest rivals. Akero was founded in 2017, and is headquartered in South San Francisco, California. Like Metamodix, Akero also competes in the Biotechnology sector. Akero generates $ less revenue vs. Metamodix.

Looking for similar companies to Metamodix?

Similar Companies

Biotechnology companies in Plymouth

See 17 companies 
Biotechnology companies in Twin Cities

See 119 companies 
Pharmaceuticals & Biotechnology companies in Plymouth

See 21 companies 
Biotechnology companies in Minnesota

See 146 companies 
Pharmaceuticals & Biotechnology companies in Twin Cities

See 168 companies 
Pharmaceuticals & Biotechnology companies in Minnesota

See 206 companies 
Companies in Plymouth with revenue in $5.0-25M range

See 1,885 companies 
Companies in Plymouth with employees in 25-100 range

See 2,455 companies 
Biotechnology companies with revenue in $5.0-25M range

See 3,635 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Metamodix and Metamodix's Competitors

July 20, 2026Biospectrum Asia
AstraZeneca inks $1.5 B deal for novel oral EGFR inhibitor Zegfrovy for lung cancer with China's Dizal Pharma...
Today 6:34 AMAd-hoc-news
AstraZeneca US6549022043 Pop Art Comic Wissenschaftlerin hält Reagenzglas mit Halbtonpunkten Primärfarben Labor, Illustration mit AI erstellt. AstraZen...
July 20, 2026Bigcountryhomepage
NEW YORK CITY, NY / ACCESS Newswire / July 20, 2026 / Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or...
July 19, 2026Ad-hoc-news
AstraZeneca US6549022043 Schwarz Weiß Reportage eines Forschers mit Molekülmodell im Pharmalabor dramatisch beleuchtet, Illustration mit AI erstellt. A...
July 19, 2026Urallnews
Regulatory Protection: Protection of Up to date: Merck beats AstraZeneca to approval for first PCSK9 capsule is gaining traction inside %%GLOBAL_NEWS%%...

Frequently Asked Questions about Metamodix

  1. Who are Metamodix's top competitors?

    Metamodix's top 3 competitors are CymaBay, Blade Therapeutics, Akero.

  2. Who is similar to Metamodix?

    CymaBay is the most similar to Metamodix. Blade Therapeutics and Akero are also similar to Metamodix.

  1. Are Metamodix and CymaBay competitors?

    Yes, CymaBay is one of Metamodix’s top competitors.